Search Results for: ENDV

Revenues for the nine months ended September 30, 2019 also increased 293% to $161,720 Company is selling SofPulse(R), its noninvasive Electroceutical(R) therapeutic device, in 7 hospitals, 11 surgery centers and 14 other medical facilities The device is currently under evaluation in 112 other healthcare facilities and Endonovo expects to become a premier supplier to hospitals nationwide … Continue reading “Endonovo Therapeutics Inc. (ENDV) Revenues Up 153% in Q3, SofPulse® Already Successfully in Use at Over 30 Medical Facilities Nationwide”

Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-op SofPulse (R) use causes 500% increase in new blood vessels, 59% increase in surgical wound recovery, 57% reduction in pain at one-hour post-op, 55% less pain medication and 50% less inflammation Bioelectric medicine is a $17 billion market, … Continue reading “Endonovo Therapeutics Inc.’s (ENDV) Electroceutical Device Brings Rapid Pain Relief, Leads to 30-40% Decrease in Post-Surgical Narcotic Prescriptions”

ENDV has developed a viable pain-control solution for those seeking alternatives to highly addictive opioids The company’s flagship product is an FDA-cleared, easy-to-place, noninvasive device that delivers pulsed electromagnetic frequencies to targeted area In one study, patients treated with Endonovo technology reported a decrease in pain medication by nearly threefold Amid mounting concern about the alarming opioid-addiction … Continue reading “Endonovo Therapeutics Inc. (ENDV) Offers Bright Spot in Opioid -Addiction Space with New Pain-Management Option”

The new strategic advisor, Dr. William Li, is a globally recognized medical professional One of Li’s primary specialties is the identification of unmet medical market needs that can be addressed through technological advances Endonovo is working to develop solutions for major therapeutic needs, especially in regard to pain management Its Electroceutical® SofPulse® is clinically proven … Continue reading “Endonovo Therapeutics Inc. (ENDV) Appoints Strategic Advisor to the CEO to Explore Growth Opportunities”